BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 24, 2019
View Archived Issues
More microbes between heaven and earth
Read More
Ammonia scavenger prevents tox at the source
Read More
Dormancy, resistance are separate issues in metastasis prevention
Read More
Funding supports further phase I development of Minervax's group B Streptococcus vaccine
Read More
HIF-2alpha inhibitor reverses pulmonary vascular remodeling, inhibits RHF, promotes survival in PAH
Read More
Novel selective tankyrase inhibitor blocks proliferation of colorectal cancer cells in rodent models
Read More
KZR-616, a dual immunoproteasome subunit inhibitor for autoimmune diseases
Read More
Bermekimab demonstrates efficacy in confirmatory study in patients with hidradenitis suppurativa
Read More
First patient enrolled in phase II study of SGM-1019 for the treatment of NASH
Read More
Athersys announces positive results from exploratory study of MultiStem cell therapy in ARDS
Read More
PeptiDream announces new BBB-penetrating PDC discovery deal with Shionogi
Read More
Phase IIb study of centanafadine sustained release in adults with ADHD meets primary endpoint
Read More
Phase II data presented for andecaliximab plus nivolumab in gastric cancer
Read More
Genentech and NewLink Genetics patent IDO and TDO inhibitors
Read More
Durvalumab and tremelimumab plus chemotherapy show promising safety in patients with ESCC
Read More
Medshine Discovery synthesizes new IRAK-4 inhibitors
Read More
[18F]RO-948 PET differentiates Alzheimer's disease from other neurodegenerative conditions
Read More
NantBioScience discloses new BACE1 inhibitors
Read More
The Vanderbilt University identifies metabotropic mGlu4 receptor PAMs
Read More
Sarepta initiates open-label extension study of SRP-5051 in Duchenne muscular dystrophy
Read More
Recordati Industria Chimica e Farmaceutica divulges mGlu5 receptor PAMs
Read More
CAMP4 Therapeutics announces rare disease research collaboration with Alnylam
Read More
New phase II trial explores use of huCART19 in very high-risk subsets of pediatric B-ALL
Read More
Basilea and Roche will collaborate to study derazantinib with atezolizumab in urothelial cancer
Read More
Ironwood begins first-in-human study of CNS-penetrant sGC stimulator IW-6463
Read More
FDA places partial clinical hold on phase III study of axalimogene filolisbac in cervical cancer
Read More
